[1]
A. Nishizawa, T. Satoh, and H. Yokozeki, “Erythrodermic Psoriasis Improved by Panitumumab, But Not Bevacizumab”, Acta Derm Venereol, vol. 92, no. 4, pp. 360–361, Mar. 2012.